567
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Investigation of serum amyloid a within animal species focusing on the 1-25 amino acid region

, &
Pages 1-8 | Received 18 May 2023, Accepted 03 Oct 2023, Published online: 27 Oct 2023

References

  • Bernhardt NA, Xi W, Wang W, Hansmann UH. 2016. Simulating protein fold switching by replica exchange with tunneling. J Chem Theory Comput. 12(11):5656–5666. doi: 10.1021/acs.jctc.6b00826.
  • Cowan DF. 1995. Amyloidosis in the bottlenose dolphin, Tursiops truncatus. Vet Pathol. 32(3):311–314. doi: 10.1177/030098589503200314.
  • Cui D, Kawano H, Takahashi M, Hoshii Y, Setoguchi M, Gondo T, Ishihara T. 2002. Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species. Pathol Int. 52(1):40–45. doi: 10.1046/j.1440-1827.2002.01309.x.
  • Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. 2004. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol. 22(10):1302–1306. doi: 10.1038/nbt1012.
  • Frieg B, Gremer L, Heise H, Willbold D, Gohlke H. 2020. Binding modes of thioflavin T and Congo red to the fibril structure of amyloid-beta(1-42). Chem Commun (Camb). 56(55):7589–7592. doi: 10.1039/d0cc01161d.
  • Gade Malmos K, Blancas-Mejia LM, Weber B, Buchner J, Ramirez-Alvarado M, Naiki H, Otzen D. 2017. ThT 101: a primer on the use of thioflavin T to investigate amyloid formation. Amyloid. 24(1):1–16. doi: 10.1080/13506129.2017.1304905.
  • Gaffney PM. 2017. Amyloid A Amyloidosis. Vet Pathol. 54(1):5–8. doi: 10.1177/0300985816677150.
  • Haines MS, Ramirez E, Moore KBE, Fortin JS. 2022. Revisiting misfolding propensity of serum amyloid A1: special ­focus on the signal peptide region. Biochem Biophys Rep. 31:101284. doi: 10.1016/j.bbrep.2022.101284.
  • Higuchi K. 2013. Transmission of AA amyloidosis may cause outbreaks of amyloid A amyloidosis in chickens. Amyloid. 20(2):59–60. doi: 10.3109/13506129.2013.792802.
  • Husebekk A, Husby G, Sletten K, Skogen B, Nordstoga K. 1988. Characterization of bovine amyloid proteins SAA and AA. Scand J Immunol. 27(6):739–743. doi: 10.1111/j.1365-3083.1988.tb02408.x.
  • Lachmann HJ, Goodman HJB, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. 2007. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 356(23):2361–2371. doi: 10.1056/NEJMoa070265.
  • Lauth LM, Voigt B, Bhatia T, Machner L, Balbach J, Ott M. 2022. Heparin promotes rapid fibrillation of the basic parathyroid hormone at physiological pH. FEBS Lett. 596(22):2928–2939. doi: 10.1002/1873-3468.14455.
  • Liberta F, Loerch S, Rennegarbe M, Schierhorn A, Westermark P, Westermark GT, Hazenberg BPC, Grigorieff N, Fändrich M, Schmidt M, et al. 2019. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids. Nat Commun. 10(1):1104. doi: 10.1038/s41467-019-09033-z.
  • Lin X, Kuragano M, Watanabe K, Tokuraku K. 2021. Comparison of AA amyloid fibril morphology and serum amyloid A gene sequence in 5 animal species. Vet Pathol. 58(2):369–375. doi: 10.1177/0300985820970490.
  • Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L. 2004. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J Mol Biol. 342(1):345–353. doi: 10.1016/j.jmb.2004.06.088.
  • Lu J, Yu Y, Zhu I, Cheng Y, Sun PD. 2014. Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proc Natl Acad Sci U S A. 111(14):5189–5194. doi: 10.1073/pnas.1322357111.
  • Murakami T, Inoshima Y, Ishiguro N. 2015. Systemic AA amyloidosis as a prion-like disorder. Virus Res. 207:76–81. doi: 10.1016/j.virusres.2014.12.019.
  • Murakami T, Ishiguro N, Higuchi K. 2014. Transmission of systemic AA amyloidosis in animals. Vet Pathol. 51(2):363–371. doi: 10.1177/0300985813511128.
  • Page LJ, Suk JY, Huff ME, Lim H-J, Venable J, Yates J, Kelly JW, Balch WE. 2005. Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. Embo J. 24(23):4124–4132. doi: 10.1038/sj.emboj.7600872.
  • Real de Asua D, Costa R, Galvan JM, Filigheddu MT, Trujillo D, Cadinanos J. 2014. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol. 6:369–377. doi: 10.2147/CLEP.S39981.
  • Rising A, Gherardi P, Chen G, Johansson J, Oskarsson ME, Westermark GT, Westermark P. 2021. AA amyloid in human food chain is a possible biohazard. Sci Rep. 11(1):21069. doi: 10.1038/s41598-021-00588-w.
  • Rousseau F, Schymkowitz J, Serrano L. 2006. Protein aggregation and amyloidosis: confusion of the kinds? Curr Opin Struct Biol. 16(1):118–126. doi: 10.1016/j.sbi.2006.01.011.
  • Sato M, Ohkawa R, Yoshimoto A, Yano K, Ichimura N, Nishimori M, Okubo S, Yatomi Y, Tozuka M. 2016. Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein. Biosci Rep. 36(4) doi: 10.1042/BSR20160075.
  • Schulte T, Chaves-Sanjuan A, Mazzini G, Speranzini V, Lavatelli F, Ferri F, Palizzotto C, Mazza M, Milani P, Nuvolone M, et al. 2022. Cryo-EM structure of ex vivo fibrils associated with extreme AA amyloidosis prevalence in a cat shelter. Nat Commun. 13(1):7041. doi: 10.1038/s41467-022-34743-2.
  • Shintani-Domoto Y, Sugiura Y, Ogawa M, Sugiyama E, Abe H, Sakatani T, Ohashi R, Ushiku T, Fukayama M. 2022. N-terminal peptide fragment constitutes core of amyloid deposition of serum amyloid A: an imaging mass spectrometry study. PLoS One. 17(10):e0275993. doi: 10.1371/journal.pone.0275993.
  • Simons JP, Al-Shawi R, Ellmerich S, Speck I, Aslam S, Hutchinson WL, Mangione PP, Disterer P, Gilbertson JA, Hunt T, et al. 2013. Pathogenetic mechanisms of amyloid A amyloidosis. Proc Natl Acad Sci U S A. 110(40):16115–16120. doi: 10.1073/pnas.1306621110.
  • Skibiszewska S, Żaczek S, Dybala-Defratyka A, Jędrzejewska K, Jankowska E. 2020. Influence of short peptides with aromatic amino acid residues on aggregation properties of serum amyloid A and its fragments. Arch Biochem Biophys. 681:108264. doi: 10.1016/j.abb.2020.108264.
  • Sun L, Ye RD. 2016. Serum amyloid A1: structure, function and gene polymorphism. Gene. 583(1):48–57. doi: 10.1016/j.gene.2016.02.044.
  • Tojo K, Tokuda T, Hoshii Y, Fu X, Higuchi K, Matsui T, Kametani F, Ikeda S-I. 2005. Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan. Amyloid. 12(2):103–108. doi: 10.1080/13506120500107097.
  • Vahdat Shariat Panahi A, Hultman P, Ollinger K, Westermark GT, Lundmark K. 2019. Lipid membranes accelerate amyloid formation in the mouse model of AA amyloidosis. Amyloid. 26(1):34–44. doi: 10.1080/13506129.2019.1576606.
  • Westermark GT, Fandrich M, Westermark P. 2015. AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol. 10(1):321–344. doi: 10.1146/annurev-pathol-020712-163913.